Purpura Fulminans After Varicella Infection and Pulmonary Embolism After COVID-19 Infection in Familial Mediterranean Fever: Coincidence or Not?
暂无分享,去创建一个
[1] Neethu M. Menon,et al. Thromboembolism in children with multisystem inflammatory syndrome: a literature review , 2022, Pediatric Research.
[2] C. Linari,et al. SARS‐COV‐2–associated coagulopathy and thromboembolism prophylaxis in children: A single‐center observational study , 2020, Journal of Thrombosis and Haemostasis.
[3] Y. Hu,et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.
[4] Simin Zhang,et al. Purpura fulminans from reduced protein S following cytomegalovirus and varicella infection , 2019, American journal of hematology.
[5] E. Ben-Chetrit,et al. Familial Mediterranean Fever and Hypercoagulability , 2011, Mediterranean journal of hematology and infectious diseases.
[6] I. Uthman,et al. Childhood stroke in a child with familial Mediterranean fever carrying several prothrombotic risk factors , 2009, Lupus.
[7] A. Ozkan,et al. Is Familial Mediterranean Fever a thrombotic disease or not? , 2008, European Journal of Pediatrics.
[8] K. Kavaklı,et al. Hypercoagulability: interaction between inflammation and coagulation in familial Mediterranean fever , 2007, Clinical Rheumatology.
[9] C. Esmon. Inflammation and thrombosis , 2003, Journal of thrombosis and haemostasis : JTH.
[10] A. Zaglio. [Update on familial Mediterranean fever]. , 1995, Revista de medicina de la Universidad de Navarra.
[11] R. Marlar,et al. Proposed Classification and Pathologic Mechanisms of Purpura Fulminans and Skin Necrosis , 1990, Seminars in thrombosis and hemostasis.
[12] D. Jatužis,et al. The Role of Colchicine in the Prevention of Cerebrovascular Ischemia. , 2018, Current pharmaceutical design.
[13] O. Kasapcopur,et al. Familial Mediterranean fever in childhood: a single-center experience , 2017, Rheumatology International.